Sort
48,018 grants matching “immunotherapy”
Differentiation of subsets of NKT cells
$539,188Mitchell Kronenberg · La Jolla Institute For Immunology · R01 · FY2017 · AI
Differentiation of subsets of NKT cells
$539,188Mitchell Kronenberg · La Jolla Institute For Immunology · R01 · FY2016 · AI
Project 3
$539,108Branden S Moriarity · University Of Minnesota · P01 · FY2022 · CA
Project 3
$539,108Branden S Moriarity · University Of Minnesota · P01 · FY2023 · CA
PAG is a novel target in immunotherapy
$539,081Adam Mor · Columbia University Health Sciences · R01 · FY2024 · AI
Systems analysis of mechanisms driving response to immunotherapy in clear cell cancers
$539,080Andrew J. Gentles · Stanford University · U01 · FY2022 · CA
(PQ8) Patient- and tumor-specific biomarkers and mechanisms that predict irAEs resulting from checkpoint inhibition
$538,983Justin M Balko · Vanderbilt University Medical Center · R01 · FY2019 · CA
Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1
$538,908Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Intravesical Immunotherapy of Spontaneous Canine Invasive Urothelial Carcinoma
$538,904David Zaharoff · North Carolina State University Raleigh · U01 · FY2022 · CA
Immune modulation of radiation therapy with Flt3 ligand
$538,873Tibor Keler · Celldex Therapeutics, Inc. · R44 · FY2016 · CA
Multimodal Imaging and Therapy of Ovarian Cancer
$538,867Vikas Kundra · University Of Maryland Baltimore · R01 · FY2025 · CA
Characterizing the regulation of PD-1 ligands in head and neck cancer stem cells using an autologous humanized model with T cell education capability
$538,860Antonio Jimeno · University Of Colorado Denver · R01 · FY2020 · CA
Immune Dysregulation by Human Papillomavirus during Head and Neck Cancer Progression
$538,851Dohun Pyeon · University Of Colorado Denver · R01 · FY2016 · DE
Innate Immunity Stimulation via CpG ODN in a Non-Human Primate Model of Sporadic Cerebral Amyloid Angiopathy
$538,831Henrieta Scholtzova · New York University School Of Medicine · R01 · FY2021 · NS
Analysis of galectin-8 and its ligands in melanoma progression
$538,782Charles J Dimitroff · Florida International University · R01 · FY2025 · CA
Pediatric AIDS Clinical Trials Unit
$538,769Duke University · U01 · FY2004 · AI
Targeting gasdermin D to treat myelodysplastic syndromes
$538,762Peng Ji · Northwestern University At Chicago · R01 · FY2025 · HL
Targeting gasdermin D to treat myelodysplastic syndromes
$538,762Peng Ji · Northwestern University At Chicago · R01 · FY2023 · HL
Elucidation of Human Natural Killer Cell Development
$538,711Aharon G Freud · Ohio State University · R01 · FY2024 · CA
Targeting PIM-2 Kinase for Improving Cancer Immunotherapy
$538,665Xue-Zhong Yu · Medical College Of Wisconsin · R01 · FY2025 · CA
Analysis of Human Immune Reponses in Cancer Vaccine Clinical Trials
$538,509Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Molecular Pharmacology Lab
$538,464Leonard Freedmand · Leidos Biomedical Research, Inc. · N01 · FY2020 · CA
Oncology Research Career Development Program
$538,380City Of Hope/Beckman Research Institute · K12 · FY2003 · CA
ANTIIDIOTYPE THERAPY OF HUMAN B CELL MALIGNANCY
$538,364Stanford University · R37 · FY2001 · CA
Kinetic Assembly of Polymer-mRNA Nanoparticles Targets Circulating Monocytes to Enhance Cancer Immunotherapy
$538,330Hai-Quan Mao · Johns Hopkins University · R01 · FY2024 · CA